During the last session, Fulcrum Therapeutics Inc (NASDAQ:FULC)’s traded shares were 0.42 million, with the beta value of the company hitting 2.23. At the end
The biotechnology industry develops mechanisms for treating health problems and tools for diagnosing them. It usually takes a great deal of research and funding for
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
